High-Throughput Screening (HTS)

Discovery - Biology


The High Volume Biology group advances the identification of novel modulators of targets by designing, optimizing, and running high-throughput screening (HTS) campaigns that deliver the critical starting points for therapeutic optimization.

We have a seasoned team of scientists with over eight decades of combined experience in drug discovery research and HTS, with expertise spanning HTS assay development, assay optimization, assay miniaturization, and hit-to-lead optimization support, including automated compound dose response follow-up and compound profiling. The team employs multiple robotic, liquid handling and detection platforms, along with robust processes, to deliver the highest quality results.

Our HTS capabilities include:

  • State-of-the-art screening system anchored by two HighRes Biosolutions robotic platforms
  • Comprehensive and flexible suite of instrumentation for liquid handling, environmental control, and detection
  • Compound and sample management